Role of the transcription factor Bcl11b in development and lymphomagenesis

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 88, Issue 3, 2012, Pages 72-87

  Kominami, Ryo ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Bcl11b; Haploinsufficient tumor suppressor; T cell development; T cell leukemia; Thymic lymphoma

Indexed keywords

BCL11B PROTEIN, HUMAN; BCL11B PROTEIN, MOUSE; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; CANCER STEM CELL; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; HAPLOINSUFFICIENCY; HUMAN; LYMPHOMA; METABOLISM; PATHOLOGY; REVIEW; THYMOCYTE;

ANIMALS; HAPLOINSUFFICIENCY; HUMANS; LYMPHOMA; NEOPLASTIC STEM CELLS; REPRESSOR PROTEINS; THYMOCYTES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84860785006     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.88.72     Document Type: Review

References (96)

1. Liu, P., Li, P. and Burke, S. (2010) Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. Immunol. Rev. 238, 138-149.
2. Wakabayashi, Y., Inoue, J., Takahashi, Y., Matsuki, A., Kosugi-Okano, H., Shinbo, T., Mishima, Y., Niwa, O. and Kominami, R. (2003) Homozygous deletions and point mutations of the Rit1/Bcl11b gene in γ-ray induced mouse thymic lymphomas. Biochem. Biophys. Res. Commun. 301, 598-603.
3. Wakabayashi, Y., Watanabe, H., Inoue, J., Takeda, N., Sakata, J., Mishima, Y., Hitomi, J., Yamamoto, T., Utsuyama, M., Niwa, O., Aizawa, S. and Kominami, R. (2003) Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat. Immunol. 4, 533-539.
4. Arlotta, P., Molyneaux, B.J., Chen, J., Inoue, J., Kominami, R. and Macklis, J.D. (2005) Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45, 207-221.
5. Golonzhka, O., Liang, X., Messaddeq, N., Bornet, J.M., Campbell, A.L., Mertzger, D., Chambon, P., Ganguli-Indra, G., Leid, M. and Indra, A. (2009) Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation. J. Invest. Dermatol. 129, 1459-1470.
6. Golonzhka, O., Metzger, D., Bornert, J.M., Bay, B.K., Gross, M.K., Kioussi, C. and Leid, M. (2009) Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis. Proc. Natl. Acad. Sci. U.S.A. 106, 4278-4283.
7. Okumura, H., Miyasaka, Y., Morita, Y., Nomura, T., Mishima, Y., Takahashi, S. and Kominami, R. (2011) Bcl11b heterozygosity leads to age-related hearing loss and degeneration of outer hair cells of the mouse cochlea. Exp. Anim. 60, 355-361.
8. Matsumoto, Y., Kosugi, S., Shinbo, T., Chou, D., Ohashi, M., Wakabayashi, Y., Sakai, K., Okumoto, M., Mori, N., Aizawa, S., Niwa, O. and Kominami, R. (1998) Allelic loss analysis of γ-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16. Oncogene 16, 2747-2754.
9. Shinbo, T., Matsuki, A., Matsumoto, Y., Kosugi, S., Takahashi, Y., Niwa, O. and Kominami, R. (1999) Allelic loss mapping and physical delineation of aregion harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12. Oncogene 18, 4131-4136.
10. Okano, H., Saito, Y., Miyazawa, T., Shinbo, T., Chou, D., Kosugi, S., Takahashi, Y., Odani, S., Niwa, O. and Kominami, R. (1999) Homozygous deletions and point mutations of the Ikaros gene in γ-ray-induced mouse thymic lymphomas. Oncogene 18, 6677-6683.
11. Georgopoulos, K., Moore, D.D. and Derfler, B. (1992) Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258, 808-812.
12. Winandy, S., Wu, P. and Georgopoulos, K. (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83, 289-299.
13. Satterwhite, E., Sonoki, T., Willis, T.G., Harder, L., Nowak, R., Arriola, E.L., Liu, H., Price, H.P., Gesk, S., Steinemann, D., Schlegelberger, B., Oscier, D.G., Siebert, R., Tucker, P.W. and Dyer, M.J.S. (2001) The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98, 3413-3420.
14. Liu, P., Keller, J.R., Ortiz, M., Tessarollo, L., Rachel, R.A., Nakamura, T., Jenkins, N.A. and Copeland, N.G. (2003) Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4, 525-532.
15. 2 zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J. Biol. Chem. 275, 10315-10322.
16. Wang, L.H., Tsai, S.Y., Cook, R.G., Beattie, W.G., Tsai, M.J. and O'Malley, B.W. (1989) COUP transcription factor is a member of the steroid receptor superfamily. Nature 340, 163-166.
17. Shibata, H., Nawaz, Z., Tsai, S.Y., O'Malley, B.W. and Tsai, M.J. (1997) Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (NCoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11, 714-724.
18. Cismasiu, V.B., Adamo, K., Gecewicz, J., Duque, J., Lin, Q. and Avram, D. (2005) BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. Oncogene 24, 6753-6764.
19. Topark-Ngarm, A., Golonzhka, O., Peterson, V.J., Barrett, B.Jr., Martinez, B., Crofoot, K., Filtz, T.M. and Leid, M. (2006) CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. J. Biol. Chem. 281, 32272-32283.
20. Guo, P., Hirano, M., Herrin, B.R., Li, J., Yu, C., Sadlonova, A. and Cooper, M.D. (2009) Dual nature of the adaptive immune system in lampreys.Nature 459, 796-801.
21. Bajoghli, B., Guo, P., Aghaallaei, N., Hirano, M., Strohmeier, C., McCurley, N., Bockman, D.E., Schorpp, M., Cooper, M.D. and Boehm, T. (2009) Evolution of genetic networks underlying the emergence of thymopoiesis in vertebrates. Cell 138, 186-197.
22. Ikawa, T., Hirose, S., Masuda, K., Kakugawa, K., Satoh, R., Shibano-Satoh, A., Kominami, R., Katsura, Y. and Kawamoto, H. (2010) An essential developmental checkpoint for production of the T cell lineage. Science 329, 93-96.
23. Nakamura, T., Yamazaki, Y., Saiki, Y., Moriyama, M., Largaespada, D.A., Jenkins, N.A. and Copeland, N.G. (2000) Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product. Mol. Cell. Biol. 20, 3178-3186.
24. Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., Best, S., Spector, T.D., Farrall, M., Lathrop, M. and Thein, S.L. (2007) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39, 1197-1199.
25. Uda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V.G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., Piras, M.G., Sestu, N., Lai, S., Dei, M., Mulas, A., Crisponi, L., Naitza, S., Asunis, I., Deiana, M., Nagaraja, R., Perseu, L., Satta, S., Cipollina, M.D., Sollaino, C., Moi, P., Hirschhorn, J.N., Orkin, S.H., Abecasis, G.R., Schlessinger, D. and Cao, A. (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia. Proc. Natl. Acad. Sci. U.S.A. 105, 1620-1625.
26. Sankaran, V.G., Menne, T.F., Xu, J., Akie, T.E., Lettre, G., Van Handel, B., Mikkola, H.K., Hirschhorn, J.N., Cantor, A.B. and Orkin, S.H. (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322, 1839-1842.
27. Sankaran, V.G., Xu, J., Ragoczy, T., Ippolito, G.C., Walkley, C.R., Maika, S.D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M.A., Tucker, P.W. and Orkin, S.H. (2009) Developmental and speciesdivergent globin switching are driven by BCL11A. Nature 460, 1093-1097.
28. Borg, J., Papadopoulos, P., Georgitsi, M., Gutiérrez, L., Grech, G., Fanis, P., Phylactides, M., Verkerk, A.J., van der Spek, P.J., Scerri, C.A., Cassar, W., Galdies, R., van Ijcken, W., Özgür, Z., Gillemans, N., Hou, J., Bugeja, M., Grosveld, F.G., von Lindern, M., Felice, A.E., Patrinos, G.P. and Philipsen, S. (2010) Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat. Genet. 42, 801-805.
29. Zhou, D., Liu, K., Sun, C.W., Pawlik, K.M. and Townes, T.M. (2010) KLF1 regulates BCL11A expression and γ-to β-globin gene switching. Nat.Genet. 42, 742-744.
30. Avram, D., Fields, A., Senawong, T., Topark-Ngarm, A. and Leid, M. (2002) COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. Biochem. J. 368, 555-563.
31. Cismasiu, V.B., Duque, J., Paskaleva, E., Califano, D., Ghanta, S., Young, H.A. and Avram, D. (2009) BCL11B enhances TCR/CD28-triggered NF-κB activation through up-regulation of Cot kinase gene expression in T-lymphocytes. Biochem. J. 417, 457-466.
32. Gutierrez, A., Kentsis, A., Sanda, T., Holmfeldt, L., Chen, S.C., Zhang, J., Protopopov, A., Chin, L., Dahlberg, S.E., Neuberg, D.S., Silverman, L.B., Winter, S.S., Hunger, S.P., Sallan, S.E., Zha, S., Alt, F.W., Downing, J.R., Mullighan, C.G. and Look, A.T. (2011) The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood 118, 4169-4173.
33. Marban, C., Redel, L., Suzanne, S., Van Lint, C., Lecestre, D., Chasserot-Golaz, S., Leid, M., Aunis, D., Schaeffer, E. and Rohr, O. (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 26, 412-423.
34. Senawong, T., Peterson, V.J., Avram, D., Shepherd, D.M., Frye, R.A., Minucci, S. and Leid, M. (2003) Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J. Biol. Chem. 278, 43041-43050.
35. Senawong, T., Peterson, V.J. and Leid, M. (2005) BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. Arch. Biochem. Biophys. 434, 316-325.
36. + T lymphocytes. Blood 108, 2695-2702.
37. WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene 28, 3380-3389.
38. Obata, M. Kominami, R. and Mishima, Y. (2012) BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner. Cell. Signal. 24, 1047-1052.
39. + thymocytes. Eur. J. Immunol. 40, 2143-2154.
40. He, X., He, X., Dave, V.P., Zhang, Y., Hua, X.,Nicolas, E., Xu, W., Roe, B.A. and Kappes, D.J. (2005) The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433, 826-833.
41. Setoguchi, R., Tachibana, M., Naoe, Y., Muroi, S., Akiyama, K., Tezuka, C., Okuda, T. and Taniuchi, I. (2008) Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822-825.
42. Tang, B., Di Lena, P., Schaffer, L., Head, S.R., Baldi, P. and Thomas, E.A. (2011) Genome-wide identification of Bcl11b gene targets reveals role in brainderived neurotrophic factor signaling. PLoS One 6 (9), e23691, doi:10.1371/journal.pone.0023691.
43. Albu, D.I., VanValkenburgh, J., Morin, N., Califano, D., Jenkins, N.A., Copeland, N.G., Liu, P. and Avram, D. (2007) BCL11B is required for positive selection and survival of double-positive thymocytes. J. Exp. Med. 204, 3003-3015.
44. +T lymphocytes depend on the transcription factor Bcl11b. J. Exp. Med. 207, 1687-1699.
45. Albu, D.I., VanValkenburgh, J., Morin, N., Califano, D., Jenkins, N.A., Copeland, N.G., Liu, P. and Avram, D. (2011) Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in doublepositive thymocytes. Proc. Natl. Acad. Sci. U.S.A. 108, 6211-6216.
46. Li, P., Burke, S., Wang, J., Chen, X., Ortiz, M., Lee, S.C., Lu, D., Campos, L., Goulding, D., Ng, B.L., Dougan, G., Huntly, B., Gottgens, B., Jenkins, N.A., Copeland, N.G., Colucci, F. and Liu, P. (2010) Reprogramming of T cells to natural killerlike cells upon Bcl11b deletion. Science 329, 85-89.
47. Li, L., Leid, M. and Rothenberg, E.V. (2010) An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329, 89-93.
48. Weber, B.N., Chi, A.W., Chavez, A., Yashiro-Ohtani, Y., Yang, Q., Shestova, O. and Bhandoola, A. (2011) A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476, 63-68.
49. Maillard, I., Fang, T. and Pear, W.S. (2005) Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23, 945-974.
50. Taghon, T.N., David, E.S., Zūñiga-Pflücker, J.C. and Rothenberg, E.V. (2005) Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19, 965-978.
51. Rothenberg, E.V., Moore, J.E. and Yui, M.A. (2008) Launching the T-cell-lineage developmental programme. Nat. Rev. Immunol. 8, 9-21.
52. Rothenberg, E.V., Zhang, J. and Li, L. (2010)Multilayered specification of the T-cell lineage fate. Immunol. Rev. 238, 150-168.
53. Gounari, F., Aifantis, I., Khazaie, K., Hoeflinger, S., Harada, N., Taketo, M.M. and von Boehmer, H. (2001) Somatic activation of β-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development. Nat. Immunol. 2, 863-869.
54. Xue, L., Nolla, H., Suzuki, A., Mak, T.W. and Winto, A. (2008) Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 105, 2022-2027.
55. Wada, H., Masuda, K., Satoh, R., Kakugawa, K., Ikawa, T., Katsura, Y. and Kawamoto, H. (2008) Adult T-cell progenitors retain myeloid potential. Nature 452, 768-772.
56. Bell, J.J. and Bhandoola, A. (2008) The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452, 764-767.
57. KO/KO mice. J. Immunol. 176, 5871-5879.
58. Shinkai, Y., Rathbun, G., Lam, K.P., Oltz, E.M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A.M. and Alt, F.W. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
59. Mombaerts, P., Clarke, A.R., Rudnicki, M.A., Iacomini, J., Itohara, S., Lafaille, J.J., Wang, L., Ichikawa, Y., Jaenisch, R.M., Hooper, L. and Tonegawa, S. (1992) Mutations in T-cell antigen receptor genes α and block thymocyte development at different stages. Nature 360, 225-231.
60. Shinkai, Y., Koyasu, S., Nakayama, K., Murphy, K.M., Loh, D.Y., Reinherz, E.L. and Alt, F.W. (1993) Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 259, 822-825.
61. Bogue, M.A., Zhu, C., Aguilar-Cordova, E., Donehower, L.A. and Roth, D.B. (1996) p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10, 553-565.
62. + stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med. 183, 1923-1928.
63. Haks, M.C., Krimpenfort, P.J., van den Brakel, H. and Kruisbeek, A.M. (1999) Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 11, 91-101.
64. -/- mice. Biochem. Biophys. Res. Commun. 328, 545-549.
65. Arlotta, P., Molyneaux, B.J., Jabaudon, D.,Yoshida, Y. and Macklis, J.D. (2008) Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J. Neurosci. 28 (3), 622-632.
66. Enomoto, T., Ohmoto, M., Iwata, T., Uno, A., Saitou, M., Yamaguchi, T., Kominami, R., Matsumoto, I. and Hirota, J. (2011) Bcl11b/Ctip2 controls the differentiation of vomeronasal sensory neurons in mice. J. Neurosci. 31 (28), 10159-10173.
67. Mack, J.A., Anand, S. and Maytin, E.V. (2005) Proliferation and cornification during development of the mammalian epidermis. Birth Defects Res. C Embryo Today 75, 314-329.
68. Tummers, M. and Thesleff, I. (2003) Root or crown: a developmental choice orchestrated by the differential regulation of the epithelial stem cell niche in the tooth of two rodent species. Development 130, 1049-1057.
69. Kinzler, K.W. and Vogelstein, B. (1996) Lessons form hereditary colorectal cancer. Cell 87, 159-170.
70. Vousden, K.H. and Prives, C. (2009) Blinded by the light: the growing complexity of p53. Cell 137, 413-431.
71. Clevers, H. (2006) Wnt/β-catenin signaling in development and disease. Cell 127, 469-480.
72. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
73. Fevr, T., Robine, S., Louvard, D. and Huelsken, J. (2007) Wnt/β-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol. Cell. Biol. 27, 7551-7559.
74. Li, L. and Clevers, H. (2010) Coexistence of quiescent and active adult stem cells in mammals. Science 327, 542-545.
75. Przybylski, G.K., Dik, W.A., Wanzeck, J., Grabarczyk, P., Majunke, S., Martin-Subero, J.I., Siebert, R., Dölken, G., Ludwig, W.D., Verhaaf, B., van Dongen, J.J., Schmidt, C.A. and Langerak, A.W. (2005) Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 19, 201-208.
76. De Keersmaecker, K., Real, P.J., Gatta, G.D., Palomero, T., Sulis, M.L., Tosello, V., Van Vlierberghe, P., Barnes, K., Castillo, M., Sole, X., Hadler, M., Lenz, J., Aplan, P.D., Kelliher, M., Kee, B.L., Pandolfi, P.P., Kappes, D., Gounari, F., Petrie, H., Van der Meulen, J., Speleman, F., Paietta, E., Racevskis, J., Wiernik, P.H., Rowe, J.M., Soulier, J., Avran, D., Cavé, H., Dastugue, N., Raimondi, S., Meijerink, J.P., Cordon-Cardo, C., Califano, A. and Ferrando, A.A. (2010) The TLX1 oncogene drives aneuploidy in T cell transformation. Nat. Med. 16, 1321-1327.
77. Paganin, M. and Ferrando, A. (2011) Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.Blood Rev. 25, 83-90.
78. Kumar, M.S., Pester, R.E., Chen, C.Y., Lane, K., Chin, C., Lu, J., Kirsch, D.G., Golub, T.R. and Jacks, T. (2009) Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23, 2700-2704.
79. Alimonti, A., Carracedo, A., Clohessy, J.G., Trotman, L.C., Nardella, C., Egia, A., Salmena, L., Sampieri, K., Haveman, W.J., Brogi, E., Richardson, A.L., Zhang, J. and Pandolfi, P.P. (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat. Genet. 42, 454-458.
80. Ohi, H., Mishima, Y., Kamimura, K., Maruyama, M., Sasai, K. and Kominami, R. (2007) Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after γ-irradiation. Oncogene 26, 5280-5289.
81. Kamimura, K., Mishima, Y., Obata, M., Endo, T., Aoyagi, Y. and Kominami, R. (2007) Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages. Oncogene 26, 5840-5850.
82. Kamimura, K., Ohi, H., Kubota, T., Okazuka, K., Yoshikai, Y., Wakabayashi, Y., Aoyagi, Y., Mishima, Y. and Kominami, R. (2007) Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development. Biochem. Biophys. Res. Commun. 355, 538-542.
83. Grabarczyk, P., Przybylski, G.K., Depke, M., Völker, U., Bahr, J., Assmus, K., Bröker, B.M., Walther, R. and Schmidt, C.A. (2007) Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene 26, 3797-3810.
84. Bartkova, J., Horejsí, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J.M., Lukas, C., Ørntoft, T., Lukas, J. and Bartek, J. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870.
85. Gorgoulis, V.G., Vassiliou, L.V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R.A. Jr., Kastrinakis, N.G., Levy, B., Kletsas, D., Yoneta, A., Herlyn, M., Kittas, C. and Halazonetis, T.D. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913.
86. Sado, T., Kamisaku, H. and Kubo, E. (1991) Bone marrow-thymus interactions during thymic lymphomagenesis induced by fractionated radiation exposure in B10 mice: Analysis using bone marrowtransplantation between Thy 1 congenic mice. J. Radiat. Res. 32, 168-180.
87. Kominami, R. and Niwa, O. (2006) Radiation carcinogenesis in mouse thymic lymphomas. Cancer Sci. 97, 575-581.
88. Larson, R.C., Lavenir, I., Larson, T.A., Baer, R., Warren, A.J., Wadman, I., Nottage, K. and Rabbitts, T.H. (1996) Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15, 1021-1027.
89. Chervinsky, D.S., Lam, D.H., Melman, M.P., Gross, K.W. and Aplan, P.D. (2001) scid Thymocytes with TCRβ gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. Cancer Res. 61, 6382-6387.
90. McCormack, M.P., Young, L.F., Vasudevan, S., de Graaf, C.A., Codrington, R., Rabbitts, T.H., Jane, S.M. and Curtis, D.J. (2010) The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 327, 879-883.
91. Curtis, D.J. and McCormack, M.P. (2010) The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia. Clin. Cancer Res. 16, 5618-5623.
92. Go, R., Hirose, S., Morita, S., Yamamoto, T., Katsuragi, Y., Mishima, Y. and Kominami, R. (2010) Bcl11b heterozygosity promotes clonal expansion and differentiation arrest of thymocytes in γ-irradiated mice. Cancer Sci. 101, 1347-1353.
93. Yamamoto, T., Morita, S., Go, E., Obata, M., Katsuragi, Y., Fujita, Y., Maeda, Y., Yokoyama, M., Aoyagi, Y., Ichikawa, H., Mishima, Y. and Kominami, R. (2010) Clonally expanding thymocytes having lineage capability in γ-ray induced mouse atrophic thymus. Int. J. Radiation Oncology Biol. 77, 235-243.
94. Lai, J.C., Wlodarska, M., Liu, D.J., Abraham, N. and Johnson, P. (2010) CD45 regulates migration, proliferation, and progression of double negative 1 thymocytes. J. Immunol. 185, 2059-2070.
95. Calabretta, B. and Perrotti, D. (2004) The biology of CML blast crisis. Blood 103, 4010-4022.
96. Clarke, M.F., Dick, J.E., Dirks, P.B., Eaves, C.J., Jamieson, C.H., Jones, D.L., Visvader, J., Weissman, I.L. and Wahl, G.M. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339-9344.